Prospects for neural stem cell-based therapies for neurological diseases
- PMID: 17920551
- PMCID: PMC7479678
- DOI: 10.1016/j.nurt.2007.08.005
Prospects for neural stem cell-based therapies for neurological diseases
Abstract
Neural stem and progenitor cells have great potential for the treatment of neurological disorders. However, many obstacles remain to translate this field to the patient's bedside, including rationales for using neural stem cells in individual neurological disorders; the challenges of neural stem cell biology; and the caveats of current strategies of isolation and culturing neural precursors. Addressing these challenges is critical for the translation of neural stem cell biology to the clinic. Recent work using neural stem cells has yielded novel biologic concepts such as the importance of the reciprocal interaction between neural stem cells and the neurodegenerative environment. The prospect of using transplants of neural stem cells and progenitors to treat neurological diseases requires a better understanding of the molecular mechanisms of both neural stem cell behavior in experimental models and the intrinsic repair capacity of the injured brain.
Similar articles
-
Human embryonic stem cells: an experimental and therapeutic resource for neurological disease.J Neurol Sci. 2008 Feb 15;265(1-2):84-8. doi: 10.1016/j.jns.2007.09.008. Epub 2007 Oct 24. J Neurol Sci. 2008. PMID: 17920631 Review.
-
Genetically engineered human neural stem cells for brain repair in neurological diseases.Brain Dev. 2007 May;29(4):193-201. doi: 10.1016/j.braindev.2006.07.012. Epub 2007 Feb 15. Brain Dev. 2007. PMID: 17303360 Review.
-
Neural stem cells and the future treatment of neurological diseases: raising the standard.Methods Mol Biol. 2008;438:9-16. doi: 10.1007/978-1-59745-133-8_2. Methods Mol Biol. 2008. PMID: 18369745
-
Opinion: neural stem cell therapy for neurological diseases: dreams and reality.Nat Rev Neurosci. 2002 May;3(5):401-9. doi: 10.1038/nrn809. Nat Rev Neurosci. 2002. PMID: 11988779 Review.
-
Reality and immortality--neural stem cells for therapies.Nat Biotechnol. 2004 Mar;22(3):283-5. doi: 10.1038/nbt0304-283. Nat Biotechnol. 2004. PMID: 14990948 No abstract available.
Cited by
-
The role of animal models in evaluating reasonable safety and efficacy for human trials of cell-based interventions for neurologic conditions.J Cereb Blood Flow Metab. 2009 Jan;29(1):1-9. doi: 10.1038/jcbfm.2008.98. Epub 2008 Aug 27. J Cereb Blood Flow Metab. 2009. PMID: 18728679 Free PMC article. Review.
-
In vivo bioluminescence imaging for viable human neural stem cells incorporated within in situ gelatin hydrogels.EJNMMI Res. 2014 Dec;4(1):61. doi: 10.1186/s13550-014-0061-3. Epub 2014 Nov 12. EJNMMI Res. 2014. PMID: 26116122 Free PMC article.
-
PKA-GSK3β and β-Catenin Signaling Play a Critical Role in Trans-Resveratrol Mediated Neuronal Differentiation in Human Cord Blood Stem Cells.Mol Neurobiol. 2018 Apr;55(4):2828-2839. doi: 10.1007/s12035-017-0539-x. Epub 2017 Apr 28. Mol Neurobiol. 2018. PMID: 28455695
-
Interaction of Notch and gp130 signaling in the maintenance of neural stem and progenitor cells.Cell Mol Neurobiol. 2014 Jan;34(1):1-15. doi: 10.1007/s10571-013-9996-6. Epub 2013 Oct 17. Cell Mol Neurobiol. 2014. PMID: 24132391 Free PMC article. Review.
-
Rhesus monkey neural stem cell transplantation promotes neural regeneration in rats with hippocampal lesions.Neural Regen Res. 2016 Sep;11(9):1464-1470. doi: 10.4103/1673-5374.191221. Neural Regen Res. 2016. PMID: 27857751 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical